JESSICA HICKS: Open Payments
NPI 1326308727 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 100 payments from 17 companies in 2025. Trend: 2023 $2,472 · 2024 $2,300 · 2025 $1,918
Food & beverage: $1,918
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 36 | $463 |
| AstraZeneca Pharmaceuticals LP | 10 | $270 |
| Verona Pharma, Inc. | 12 | $232 |
| GENZYME CORPORATION | 8 | $202 |
| Grifols USA, LLC | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Genentech USA, Inc. | 5 | $91 |
| Viatris Specialty LLC | 3 | $87 |
| Amgen Inc. | 4 | $82 |
| United Therapeutics Corporation | 3 | $62 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Ohtuvayre, NUCALA, AIRSUPRA, Prolastin-C Liquid, TEZSPIRE, GLASSIA.
Industry payments across KY — which companies pay providers there.
